RHI Stock Analysis: Robert Half International | NYSE
Staffing & Employment Services | NYSE, USA | Market Cap: 4.615m USD | 12M Return: 32.3% | US7703231032 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 73.7M
EPS Trend: -99.7%
Qual. Beats: 0
Rev. Trend: -98.1%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Robert Half Inc. (NYSE: RHI) is a global talent solutions and business consulting firm headquartered in Menlo Park, California, and founded in 1948. The company operates through three segments: Contract Talent Solutions, which places temporary professionals in fields such as finance, accounting, technology, legal, and marketing; Permanent Placement Talent Solutions, focused on full-time accounting, finance, and tax roles; and Protiviti, its consulting arm offering services in risk, compliance, technology, internal audit, and digital transformation. The firm primarily markets its services under the Robert Half and Protiviti brands through digital advertising, job boards, alliance partners, and events. The company was previously known as Robert Half International Inc. before rebranding in July 2023.
As a member of the Industrials sector within the Human Resource & Employment Services sub-industry, Robert Half generates revenue from both temporary staffing margins and permanent placement fees, with its Protiviti segment providing higher-margin advisory work that diversifies the business beyond traditional staffing. Staffing firms like RHI tend to be cyclical, with demand closely tied to labor market conditions and corporate hiring trends.
- Contract staffing revenue pressured by corporate hiring freezes
- Protiviti consulting demand grows on regulatory compliance needs
- Tech talent placement faces competition from online staffing platforms
| Net Income: 114.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -2.53 > 1.0 |
| NWC/Revenue: 12.88% < 20% (prev 13.56%; Δ -0.68% < -1%) |
| CFO/TA 0.09 > 3% & CFO 256.3m > Net Income 114.8m |
| Net Debt (-83.9m) to EBITDA (149.3m): -0.56 < 3 |
| Current Ratio: 1.47 > 1.5 & < 3 |
| Outstanding Shares: last quarter (100.3m) vs 12m ago -0.47% < -2% |
| Gross Margin: 36.80% > 18% (prev 37.62%; Δ -0.82% > 0.5%) |
| Asset Turnover: 186.0% > 50% (prev 196.6%; Δ -10.60% > 0%) |
| Interest Coverage Ratio: 0.75 > 6 (EBIT TTM 79.8m / Interest Expense TTM 106.1m) |
| A: 0.24 (Total Current Assets 2.14b - Total Current Liabilities 1.46b) / Total Assets 2.86b |
| B: 0.0 (Retained Earnings 0.0 / Total Assets 2.86b) |
| C: 0.03 (EBIT TTM 79.8m / Avg Total Assets 2.85b) |
| D: 0.73 (Book Value of Equity 1.21b / Total Liabilities 1.65b) |
| Altman-Z'' = 2.52 = A |
| DSRI: 1.05 (Receivables 821.4m/826.9m, Revenue 5.29b/5.57b) |
| GMI: 1.02 (GM 37.62% / 36.80%) |
| AQI: 0.93 (AQ_t 0.14 / AQ_t-1 0.15) |
| SGI: 0.95 (Revenue 5.29b / 5.57b) |
| TATA: -0.05 (NI 114.8m - CFO 256.3m) / TA 2.86b) |
| Beneish M = -3.05 (Cap -4..+1) = AA |
As of September 01, 2026, the stock is trading at USD 45.34 with a total of 2,505,570 shares traded. Over the past week, the price has changed by +1.82%, over one month by +21.54%, over three months by +48.24% and over the past year by +32.26%.
Current recommended Stop Loss: 42.90 (which is 5.4% or 1.4 ATR below the current price).
Robert Half International has received a consensus analysts rating of 2.91. Therefore, it is recommended to hold RHI.
- StrongBuy: 2
- Buy: 0
- Hold: 6
- Sell: 1
- StrongSell: 2
| Analysts Target Price | 35 | -22.8% |
P/E Trailing = 38.8966
P/E Forward = 12.9702
P/S = 0.8719
P/B = 3.793
P/EG = 5.4559
Revenue TTM = 5.29b USD
EBIT TTM = 79.8m USD
EBITDA TTM = 149.3m USD
Long Term Debt = 174.3m USD (estimated: total debt 240.8m - short term 66.5m)
Short Term Debt = 66.5m USD (from shortTermDebt, last quarter)
Debt = 240.8m USD (from shortLongTermDebtTotal, last quarter) (leases 240.8m already included)
Net Debt = -83.9m USD (calculated: Debt 240.8m - CCE 324.7m)
Enterprise Value = 4.53b USD (4.62b + Debt 240.8m - CCE 324.7m)
Interest Coverage Ratio = 0.75 (Ebit TTM 79.8m / Interest Expense TTM 106.1m)
EV/FCF = 21.07x (Enterprise Value 4.53b / FCF TTM 215.1m)
FCF Yield = 4.75% (FCF TTM 215.1m / Enterprise Value 4.53b)
FCF Margin = 4.06% (FCF TTM 215.1m / Revenue TTM 5.29b)
Net Margin = 2.17% (Net Income TTM 114.8m / Revenue TTM 5.29b)
Gross Margin = 36.80% ((Revenue TTM 5.29b - Cost of Revenue TTM 3.35b) / Revenue TTM)
Gross Margin QoQ = 35.47% (prev 36.91%)
Tobins Q-Ratio = 1.59 (Enterprise Value 4.53b / Total Assets 2.86b)
Interest Expense / Debt = 44.06% (Interest Expense 106.1m / Debt 240.8m)
Taxrate = 37.17% (67.9m / 182.7m)
NOPAT = 50.1m (EBIT 79.8m * (1 - 37.17%))
Current Ratio = 1.47 (Total Current Assets 2.14b / Total Current Liabilities 1.46b)
Debt / Equity = 0.20 (Debt 240.8m / totalStockholderEquity, last quarter 1.21b)
Debt / EBITDA = -0.56 (Net Debt -83.9m / EBITDA 149.3m)
Debt / FCF = -0.39 (Net Debt -83.9m / FCF TTM 215.1m)
Total Stockholder Equity = 1.25b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.03% (Net Income 114.8m / Total Assets 2.86b)
RoE = 9.18% (Net Income TTM 114.8m / Total Stockholder Equity 1.25b)
RoCE = 5.60% (EBIT 79.8m / Capital Employed (Equity 1.25b + L.T.Debt 174.3m))
RoIC = 4.16% (NOPAT 50.1m / Invested Capital 1.20b)
WACC = 9.40% (E(4.62b)/V(4.86b) * Re(8.45%) + D(240.8m)/V(4.86b) * Rd(44.06%) * (1-Tc(0.37)))
Discount Rate = 8.45% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -92.53 | Cagr: -1.76%
[DCF] Terminal Value 69.25% ; FCFF base≈242.9m ; Y1≈213.0m ; Y5≈172.1m
[DCF] Fair Price = 23.84 (EV 2.35b - Net Debt -83.9m = Equity 2.44b / Shares 102.3m; r=9.40% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -99.67 | EPS CAGR: -39.50% | SUE: 0.0 | # QB: 0
Revenue Correlation: -98.13 | Revenue CAGR: -7.71% | SUE: 0.56 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.47 | Chg30d=-0.19% | Revisions=+38% | Analysts=8
EPS current Year (2026-12-31): EPS=1.27 | Chg30d=-3.16% | Revisions=-18% | GrowthEPS=-4.2% | GrowthRev=-1.2%
EPS next Year (2027-12-31): EPS=1.97 | Chg30d=-4.42% | Revisions=-25% | GrowthEPS=+55.0% | GrowthRev=+4.1%
[Analyst] Revisions Ratio: -8% (up=10, down=12)